Birchenall-Roberts M C, Ruscetti F W, Kasper J, Lee H D, Friedman R, Geiser A, Sporn M B, Roberts A B, Kim S J
Division of Cancer Treatment, National Cancer Institute, Frederick Cancer Research Facility, Maryland 21701.
Mol Cell Biol. 1990 Sep;10(9):4978-83. doi: 10.1128/mcb.10.9.4978-4983.1990.
Growth factor-independent 32D-src and 32D-abl cell lines, established by infecting the interleukin-3-dependent myeloid precursor cell line (32D-123) with retroviruses containing the src or abl oncogene, were used to study transcriptional regulation of transforming growth factor beta 1 (TGF-beta 1) mRNA. Analysis of different TGF-beta 1 promoter constructs regulated by pp60v-src indicated that sequences responsive to high levels of src induction contain binding sites for AP-1. Both src and serum induced expression of the c-fos and c-jun genes in myeloid cells, resulting in transcriptional activation of the TGF-beta 1 gene. We found that serum treatment increased TGF-beta 1 mRNA levels in 32D-123 cells and that the v-Src protein could replace the serum requirement by stimulating binding to the AP-1 complex of the TGF-beta 1 promoter, thereby mediating the induction of TGF-beta 1 transcription.
通过用含有src或abl癌基因的逆转录病毒感染白细胞介素-3依赖的髓系前体细胞系(32D-123)建立的生长因子非依赖性32D-src和32D-abl细胞系,被用于研究转化生长因子β1(TGF-β1)mRNA的转录调控。对由pp60v-src调控的不同TGF-β1启动子构建体的分析表明,对高水平src诱导有反应的序列含有AP-1的结合位点。src和血清均可诱导髓系细胞中c-fos和c-jun基因的表达,从而导致TGF-β1基因的转录激活。我们发现血清处理可增加32D-123细胞中TGF-β1 mRNA水平,并且v-Src蛋白可通过刺激与TGF-β1启动子的AP-1复合物结合来替代血清需求,从而介导TGF-β1转录的诱导。